Effects of sacubitril/valsartan versus enalapril on NT-proBNP and hs-troponin T in patients with heart failure due to Chagas disease: insights from the PARACHUTE-HF trial
Prognostically important comorbidities such as diabetes, hypertension, and coronary disease are uncommon in patients with heart failure with reduced ejection fraction (HFrEF) secondary to chronic Chagas cardiomyopathy, yet these patients have worse outcomes, including worse survival, compared with other HF etiolo...